Baxter International向Carlyle Group出售肾脏护理股,费用为3.8B美元,重点是核心企业。 Baxter International sells kidney care unit to Carlyle Group for $3.8B, focusing on core businesses.

巴克斯特国际公司向卡莱尔集团出售其肾脏护理单位38亿美元,这笔交易有望加强两家公司在透析市场的地位,并为肾病患者提供更好的护理。 Baxter International sells its kidney care unit to Carlyle Group for $3.8 billion in a deal expected to strengthen both companies' positions in the dialysis market and provide better access to care for kidney patients. Baxter将利用所得收入集中经营其核心业务,包括医院和家庭的IV疗法和药品。 Baxter will utilize the proceeds to focus on its core businesses, including hospital and home-based IV therapies and pharmaceuticals. 交易正在等待监管批准和习惯关闭条件。 The transaction is pending regulatory approvals and customary closing conditions.